Zandi PP - Search Results

1

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC; Cache County Study Group. Zandi PP, et al. Arch Neurol. 2004 Jan;61(1):82-8. doi: 10.1001/archneur.61.1.82. Arch Neurol. 2004. PMID: 14732624

2

Is pharmacological prevention of Alzheimer's a realistic goal?

Zandi PP, Breitner JC, Anthony JC. Zandi PP, et al. Expert Opin Pharmacother. 2002 Apr;3(4):365-80. doi: 10.1517/14656566.3.4.365. Expert Opin Pharmacother. 2002. PMID: 11934339 Review.

3

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study.

Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC; Cache County Study Investigators. Zandi PP, et al. Neurology. 2002 Sep 24;59(6):880-6. doi: 10.1212/wnl.59.6.880. Neurology. 2002. PMID: 12297571

4

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC; Cache County Memory Study Investigators. Zandi PP, et al. JAMA. 2002 Nov 6;288(17):2123-9. doi: 10.1001/jama.288.17.2123. JAMA. 2002. PMID: 12413371

5

Effects of estrogen plus progestin on risk of dementia.

Breitner JC, Zandi PP. Breitner JC, et al. Among authors: zandi pp. JAMA. 2003 Oct 1;290(13):1706-7; author reply 1707-8. doi: 10.1001/jama.290.13.1706-b. JAMA. 2003. PMID: 14519698 No abstract available.

6

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.

Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC; Cache County Study Investigators. Khachaturian AS, et al. Among authors: zandi pp. Arch Gen Psychiatry. 2004 May;61(5):518-24. doi: 10.1001/archpsyc.61.5.518. Arch Gen Psychiatry. 2004. PMID: 15123497

7

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN. Szekely CA, et al. Among authors: zandi pp. Neuroepidemiology. 2004 Jul-Aug;23(4):159-69. doi: 10.1159/000078501. Neuroepidemiology. 2004. PMID: 15279021 Review.

8

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC; Cache County Study investigators. Zandi PP, et al. Arch Gen Psychiatry. 2005 Feb;62(2):217-24. doi: 10.1001/archpsyc.62.2.217. Arch Gen Psychiatry. 2005. PMID: 15699299

9

Apolipoprotein E genotype and mortality: findings from the Cache County Study.

Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, Khachaturian AS, Pieper CF, Welsh-Bohmer KA, Breitner JC; Cache County Investigators. Hayden KM, et al. Among authors: zandi pp. J Am Geriatr Soc. 2005 Jun;53(6):935-42. doi: 10.1111/j.1532-5415.2005.53301.x. J Am Geriatr Soc. 2005. PMID: 15935014

10

Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH. Rea TD, et al. Among authors: zandi pp. Arch Neurol. 2005 Jul;62(7):1047-51. doi: 10.1001/archneur.62.7.1047. Arch Neurol. 2005. PMID: 16009757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page